Skip Navigation

A Phase III Study of Relacorilant in Combination with Nab- Paclitaxel versus Investigator?s Choice in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer [CORT125134-556/GOG-3073] ROSELLA Study

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT05257408

Study #:
STUDY00149961

Start Date:
Aug 02, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05257408

View Complete Trial Details & Eligibility at ClinicalTrials.gov